These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 24927147)

  • 1. Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.
    Su TH; Kao JH; Liu CJ
    Int J Mol Sci; 2014 Jun; 15(6):10578-604. PubMed ID: 24927147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.
    Mormone E; George J; Nieto N
    Chem Biol Interact; 2011 Sep; 193(3):225-31. PubMed ID: 21803030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.
    Zhang CY; Yuan WG; He P; Lei JH; Wang CX
    World J Gastroenterol; 2016 Dec; 22(48):10512-10522. PubMed ID: 28082803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NS5ATP13 Promotes Liver Fibrogenesis Via Activation of Hepatic Stellate Cells.
    Li Y; Liu S; Han M; Lu H; Wang Q; Zhang Y; Tursun K; Li Z; Feng S; Cheng J
    J Cell Biochem; 2017 Aug; 118(8):2463-2473. PubMed ID: 28133777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition.
    Kluwe J; Pradere JP; Gwak GY; Mencin A; De Minicis S; Osterreicher CH; Colmenero J; Bataller R; Schwabe RF
    Gastroenterology; 2010 Jan; 138(1):347-59. PubMed ID: 19782079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis.
    Foglia B; Cannito S; Bocca C; Parola M; Novo E
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.
    Elpek GÖ
    World J Gastroenterol; 2014 Jun; 20(23):7260-76. PubMed ID: 24966597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advancement of molecular mechanisms of liver fibrosis.
    Seki E; Brenner DA
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):512-8. PubMed ID: 25869468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis.
    Povero D; Pinatel EM; Leszczynska A; Goyal NP; Nishio T; Kim J; Kneiber D; de Araujo Horcel L; Eguchi A; Ordonez PM; Kisseleva T; Feldstein AE
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis.
    Khomich O; Ivanov AV; Bartosch B
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFβ1 and lipopolysaccharide.
    Zou Y; Cai Y; Lu D; Zhou Y; Yao Q; Zhang S
    Cell Signal; 2017 Nov; 39():1-8. PubMed ID: 28739486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-942 mediates hepatic stellate cell activation by regulating BAMBI expression in human liver fibrosis.
    Tao L; Xue D; Shen D; Ma W; Zhang J; Wang X; Zhang W; Wu L; Pan K; Yang Y; Nwosu ZC; Dooley S; Seki E; Liu C
    Arch Toxicol; 2018 Sep; 92(9):2935-2946. PubMed ID: 30097701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
    Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
    Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice.
    Troeger JS; Mederacke I; Gwak GY; Dapito DH; Mu X; Hsu CC; Pradere JP; Friedman RA; Schwabe RF
    Gastroenterology; 2012 Oct; 143(4):1073-83.e22. PubMed ID: 22750464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.
    Tan Z; Qian X; Jiang R; Liu Q; Wang Y; Chen C; Wang X; Ryffel B; Sun B
    J Immunol; 2013 Aug; 191(4):1835-44. PubMed ID: 23842754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial MicroRNA-Mediated Tgfbr2 and Pdgfrb Co-Silencing Ameliorates Carbon Tetrachloride-Induced Hepatic Fibrosis in Mice.
    Jiang Y; Zhao Y; He F; Wang H
    Hum Gene Ther; 2019 Feb; 30(2):179-196. PubMed ID: 30024280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis.
    Son G; Hines IN; Lindquist J; Schrum LW; Rippe RA
    Hepatology; 2009 Nov; 50(5):1512-23. PubMed ID: 19790269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis.
    Li S; Vriend LE; Nasser IA; Popov Y; Afdhal NH; Koziel MJ; Schuppan D; Exley MA; Alatrakchi N
    Hepatology; 2012 Dec; 56(6):2094-105. PubMed ID: 22806830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key Players of Hepatic Fibrosis.
    Dawood RM; El-Meguid MA; Salum GM; El Awady MK
    J Interferon Cytokine Res; 2020 Oct; 40(10):472-489. PubMed ID: 32845785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.